METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation is a research paper published in Journal of Hematology & Oncology (2024). On theSindex it has a DataRank of 1.6. It has been cited 82 times, with 71 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.663
From this paper's citation signal
Citation Network Contribution
0.897
From 45 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 71 citers.
U.S. National Institutes of Health
Grant: R01 CA233691
U.S. National Institutes of Health
Grant: R01 CA243386
American Association for the Study of Liver Diseases (AASLD) Foundation
Grant: PNC22-261362
NCI NIH HHS
Grant: R37 CA233691
NCI NIH HHS
Grant: R01 CA280389
NIDDK NIH HHS
Grant: R01 DK124116
NCI NIH HHS
Grant: R01 CA236626
NCI NIH HHS
Grant: R01 CA236399
NCI NIH HHS
Grant: R01 CA271497
National Institutes of Health
Grant: 5R01CA271497-03
The role and therapeutic potential of IGF2BP2 in MLL-rearranged leukemia
National Institutes of Health
Grant: 5R01CA280389-02
TET2-mediated epitranscriptomic regulation in leukemia microenvironment
National Institutes of Health
Grant: 5R01CA243386-02
Targeting FTO to treat acute myeloid leukemia
National Institutes of Health
Grant: 1R01DK124116-01
The function and underlying mechanism of TET1 in myelodysplastic syndromes
National Institutes of Health
Grant: 5R01CA236626-05
Role of BAZ2A in MLL-r leukemia and therapeutic response
National Institutes of Health
Grant: 5R01CA236399-02
The role and mechanism of METTL3/METTL14-mediated RNA modification in the pathogenesis and drug-resistance of AML
National Institutes of Health
Grant: 5R37CA233691-03
Combinational targeting the feed forward epigenetic circuitry in mixed lineage leukemia
Margaret E. Early Medical Research Trust
Leukemia Research Foundation
the Simms/Mann Family Foundation
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 2 of WTAP/IGF2BP3 mediated m6A modification of the EGR1/PTEN axis regulates the malignant phenotypes of endometrial cancer stem cells
Additional file 2 of WTAP/IGF2BP3 mediated m6A modification of the EGR1/PTEN axis regulates the malignant phenotypes of endometrial cancer stem cells
Additional file 1 of WTAP/IGF2BP3 mediated m6A modification of the EGR1/PTEN axis regulates the malignant phenotypes of endometrial cancer stem cells
Additional file 1 of WTAP/IGF2BP3 mediated m6A modification of the EGR1/PTEN axis regulates the malignant phenotypes of endometrial cancer stem cells
Additional file 3 of WTAP/IGF2BP3 mediated m6A modification of the EGR1/PTEN axis regulates the malignant phenotypes of endometrial cancer stem cells
Additional file 3 of WTAP/IGF2BP3 mediated m6A modification of the EGR1/PTEN axis regulates the malignant phenotypes of endometrial cancer stem cells